5 Results for "

DYRK2-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "DYRK2-IN-1" in MCE Product Catalog:

Cat. No.: HY-161014
CAS No.: 3036481-22-5
Target:  

DYRK

Research Areas:  

Cancer

DYRK2-IN-1 (Compd 54) is an orally bioavailable DYRK2 inhibitor, with an IC50 of 14 nM. DYRK2-IN-1 (Compd 54) can be used in the study of prostate cancer .
loading...
    loading...
Cat. No.: HY-155723
CAS No.: 2732859-57-1
Purity:  98.54%
Target:  

CDK DYRK

Research Areas:  

Others

Leucettinib-92 (compound 92) is an inhibitor of DYRK/CLK kinase, The IC50s are 147 nM (CLK1), 39 nM (CLK2), 5.2 nM (CLK4), 0.8 μM (CLK3), 124 nM (DYRK1A), 204 nM (DYRK1B), 0.16 μM (DYRK2), respectively. 1.0 μM (DYRK3), 0.52 μM (DYRK4), 2.78 μM (GSK3) .
loading...
    loading...
Cat. No.: HY-161597
CAS No.: 3061366-76-2
Target:  

PROTACs DYRK

Research Areas:  

Cancer

PROTAC DYRK2 degrader 1 is a DYRK2 PROTAC degrader with DC50 values of 1.607 μM (MDA-MB-231 cells) and 3.265 μM (HeLa cells), respectively. PROTAC DYRK2 degrader 1 induces DYRK2 degradation via the ubiquitin-proteasome system. It is applicable to the research of triple-negative breast cancer and cervical cancer .
loading...
    loading...
Cat. No.: HY-135002
CAS No.: 1233355-57-1
Target:  

Haspin Kinase

Research Areas:  

Cancer

LDN-209929 is a potent haspin kinase inhibitor, with IC50 values of 55 nM and 9.9 μM for Haspin and DYRK2, respectively .
loading...
    loading...
Cat. No.: HY-161598
Research Areas:  

Cancer

DYRK2 ligand 1 is a target protein ligand of PROTAC DYRK2 degrader 1 (HY-161597). DYRK2 ligand 1 can be used to study cancer .
loading...
    loading...